Dr. Cristina Zivko is a postdoctoral fellow at the Department of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA. Dr. Zivko received her B.Sc. and M.Sc. in Pharmaceutical Sciences from ETH Zurich. Dr. Zivko earned her Ph.D. in Chemistry and Biochemistry at the University of Bern in 2021.
Costas Demetzos is a Professor of Pharmaceutical Nanotechnology at the National and Kapodistrian University of Athens. He serves as Director of the Laboratory of Pharmaceutical Technology and since 2008 he has served as President of the Hellenic Pharmaceutical Society (HPS). His research interests are primarily in pharmaceutical nanotechnology, physical pharmacy, nanomedicine, thermodynamics and biophysics of nanoplatforms, pharmaceutical compounding and regulatory aspects. He participates as a member of Scientific Organizing Committees and as a President of International and European scientific Conferences while being an evaluator in many National and International committees. He was an elected member of the ExCo of EUFEPS (Network Coordinator) (2013–2016). At present, he is a member of the International Advisory Committee for Alzheimer’s Disease (2019–present), and of the Hellenic Initiative Against Alzheimer Disease (HIAAD) (2019–present). In 2018, Costas Demetzos was honored with an award by the Order of Sciences of the Academy of Athens for his scientific achievements in Pharmaceutical Nanotechnology. In 2021, Prof. Demetzos was elected as an Ordinary member of Class IV-Natural Sciences of the European Academy of Sciences and Arts (Academia Scientiarium et Artium Europaea). Since 2023, he has acted as Associate Editor of the prestigious Journal of Liposome Research.
Vasiliki Mahairaki is an Assistant Professor at the Department of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA. She is also a member of the Johns Hopkins Richman Family Precision Medicine Center of Excellence in Alzheimer's Disease (PMCoE-AD). Dr. Machairaki graduated with M.Sc. at the University of Patras and received a Ph.D. from the University of Crete,Greece. Dr. Machairaki's research focus for more than fifteen years has been the reprogramming of differentiated cell types, such as human fibroblasts and human blood, into pluripotent stem cells (iPSCs) and the application of this technology to studies of the nervous system and diseases that affect it.
